Medical Advocates
Didanosine (Videx)
 
Main Page

New and Noteworthy
 Drug Alerts/Warning Letters
 Guidelines
 Database of ARV Drug Interactions
 Journal Data
 Conference Data
Perinatal Index
 Pediatric Index

 
ARV Drugs Main Page Main New/Newsworthy Home Page      
This web page is best viewed by using INTERNET EXPLORER
Last Update:  July 05, 2008
  Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
New and Noteworthy
     
July  2008
 
 
Drug Alerts/Warning Letters
         
Didanosine

     Internet Documents
 
  FULL TEXT  DOCUMENT
 Abacavir or Didanosine Associated with an Increased Risk of Myocardial Infarction
 USFDA  
March 27, 2008
Drug Alert
 
Didanosine/Tenofovir and either Efavirenz or Nevirapine

     Internet Documents

  PDF LETTER
BMS Warning Letter: Important New Clinical Data Potential Early Virologic Failure
Associated with the Combination Antiretroviral Regimen of Tenofovir Disoproxil Fumarate,
Didanosine, and Either Efavirenz or Nevirapine in HIV Treatment-Naïve Patients with High
Baseline Viral Loads
Sally L. Hodder, MD,
 November 2004
Letter
 
Didanosine, Lamivudine, and Tenofovir

     Internet Documents
 
  FULL-TEXT LETTER
Drug Alert from Gilead: High Rate of Virologic Failure in Patients with HIV Infection
Treated With a Once-Daily Triple NRTI Regimen containing Didanosine, Lamivudine,
and Tenofovir
October 14, 2003
Letter
 
Patient Package Insert Updates

     Internet Documents
 
  DDI Patient Package Insert (updates shaded in yellow)
 US FDA
November 2006
 Document

ARV Drugs Main Page Main New/Newsworthy Home Page      

Didanosine Main Page